Mission of this conference

To bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.

BioPacific Conference 2010 was organized successfully on May 8, with the attendance of close to 600 life science scientists, professionals, and executives from the U.S., China and Southeast Asia.  It featured distinguished leaders of the life science industry who shared the latest breakthroughs, challenges and opportunities facing the life science industry worldwide. The evening session & banquet, jointly organized by the Chinese American BioPharmaceutical Society and China Pharmaceutical Research and Development Association, also provided a comprehensive overview of the pharmaceutical industry in China.

Main theme of BioPacific Conference 2010:  Drug Discovery and Development in Changing Times

Key sessions of the 2010 conference included:

• Global Discovery and Development

• Advances in Neuroscience
• Promising Pipelines and Technologies

• Investment and Business Opportunities in China
• The Pharmaceutical Industry in China: the Present and the Future

Date for BioPacific Conference 2011:

The 2011 conference has been tentatively scheduled for June 25, 2011, at Crowne Plaza Hotel, Foster City, CA 94404, USA.  Further details will be posted in due course.

Sponsors:

For further details, please contact Fundraising@cabsweb.org.

2010 Conference Photos:

Conference in session Vendor show Vendor show & networking Vendor booth CABS President Shichang Miao CABS Leadership with speakers from China CABS Leadership with Xiamen Delegation CABS President Shichang Miao and Sino-PHRDA Exec.President Ruilin Song CABS President Shichang Miao and SinoPharm VP Bing Zeng Charles Comey of Morrison Foerster ChemoCentryx CEO Thomas Schall Conference attendees Cytokinetics VP Bradley Morgan Genentech SVP Michael Varney Helen Chen of L.E.K. Consulting Leping Li, Robyn Rourick, Shichang Miao M.Doherty of Roche and CABS President-elect Wei Dong Zhendong Pharma VP Ruihua Jiang Yantai Luye Group Hua Jiang Genentech VP Morgan Sheng and CABS President-elect Wei Dong Roche Regulatory Head Michael Doherty Sino-PHRDA Executive President Ruilin Song OneWorld CEO Richard Chin Pharmaron CEO Boliang Lou Wuhan BioLake Director Junhua Bao Ascentage Pharma CEO Dqjun Yang Bing Zeng VP of SinoPharm Conference program books Ih-Ming Chan of Singapore Genentech VP Morgan Sheng